Sale of all interest in assets including contracts, drug application registrations, the 'Plenaxis' trademarks and trade names, patents, know-how, technical information, promotional and marketing materials, customer and supplier lists, marketing studies, product inventory and materials, manufacturing equipment, product records, government authorizations and shares, with royalty on the sale of products containing abarelix in any formulation, including the 'Plenaxis' product formulated in 'Rel-Ease' or similar formulation to treat prostate cancer, abarelix products for injectable suspension, an abarelix product to treat endometriosis including sustained release or depot formulations, and other products under sublicense.
RoyaltyStat provides an online database of license and service agreements with royalty rate analytics tools to support transfer pricing, finance, and intellectual property professionals in valuing intangibles.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The provided text is a legal notice regarding the sale of all interests in assets related to the drug abarelix, including patents and trademarks for formulations treating prostate cancer and endometriosis. It identifies RoyaltyStat as an online database used by professionals to value intangibles and analyze license agreements. The document does not contain scientific research findings or clinical data. Relevance to endometriosis: listed as one indication for abarelix products included in the asset sale, though the paper's main focus is intellectual property valuation.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
518 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-05-10T10:39:26.118035+00:00